SCHEMBL2162192

SCHEMBL2162192

CC1OCc2sc(N)c(C(=O)c3ccccc3)c21

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
MAPT P10636 4/20 0.50
LMNA P02545 4/20 0.50
HPGD P15428 2/20 0.50
GAA P10253 1/20 0.50
GRM6 O15303 1/20 0.45
NPC1 O15118 1/20 0.40
HTT P42858 1/20 0.40
RAB9A P51151 1/20 0.40
ADORA1 P30542 2/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
USP2 O75604 1/20 0.37
GLA P06280 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
RAB7A P51149 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2162435 0.82 ALDH1A1 (0.37) ALDH1A1MAPTHPGDNPC1HTT
SCHEMBL2162573 0.76 ALDH1A1 (0.38) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL2162393 0.74 CNR1 (0.38) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL2162345 0.74 CNR1 (0.38) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL2162281 0.73 ALDH1A1 (0.54) ALDH1A1MAPTHPGDGAANPC1
SCHEMBL20339216 0.73 ALOX15 (0.42) MAPTLMNANPC1HTTRAB9A
SCHEMBL4055676 0.69 ALDH1A1 (0.66) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL1637546 0.67 ALDH1A1 (1.00) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL136108 0.67 MAPT (0.94) ALDH1A1MAPTLMNAHPGDGAA
SCHEMBL5712829 0.67 MEN1 (0.77) ALDH1A1MAPTLMNAHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985768-B2 2-carbonylamino-4,6-dihydrothieno[2,3-c]furans such as ethyl 2-{[2-fluoro-6-(trifluoromethyl)benzoyl]amino}-4-methyl-4,6-dihydrothieno[2,3-c]furan-3-carboxylate; CB2 receptors ligands for immune and inflammatory conditions; pain; neuroprotectants ABBOTT LABORATORIES (US) 2011-07-26 US disclosed
WO-2008028094-A1 COMPOUNDS AS CB2 CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2008-03-06 WO disclosed
US-20080058308-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058308-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS CNR1, CNR2, OPRL1 ALDH1A1 1497/4885MAPT 1751/4885LMNA 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.